Analystreport

Harpoon Therapeutics, Inc. (NASDAQ: HARP) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.

Harpoon Therapeutics, Inc.  (HARP) 
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm Check Earnings Report